Search - tctmd.com

Displaying 341 - 360 of 415

Sort: Relevancy | Date

Presentation TCT 2015

Valve Thrombosis/Leaflet Thickening: To Treat or Not to Treat

Presenter: Nicole Ibrahim, Martin B. Leon, Raj Makkar

October 14, 2015

News Conference News TCT 2015

Companies With Innovative Technologies Compete in TCT Shark Tank

October 13, 2015

News Industry News

St. Jude Medical Announces CE Mark Approval for the HeartMate 3 Left Ventricular Assist System

October 12, 2015

News Conference News TCT 2015

Global TAVR Market Poised to Exceed DES Market by 2025

October 11, 2015

News Conference News TCT 2015

Cath Lab Economics: Pursuit of a Light at the End of the Tunnel

Nicole Lou

October 11, 2015

News Daily News

在人工动脉瓣中二尖瓣运动降低并不少见，但可通过抗凝予以治疗

L.A. McKeown

October 08, 2015

News Daily News

Reduced Leaflet Motion in Bioprosthetic Aortic Valves Not Uncommon But Remedied by Anticoagulation

L.A. McKeown

October 08, 2015

News Daily News

El Menor Movimiento de las Valvas en las Válvulas Aórticas Bioprotésicas es Habitual Pero puede Remediarse con el Uso de Anticoagulación

L.A. McKeown

October 08, 2015

Presentation

Possible Subclinical Leaflet Thrombosis in Bioprosthetic Aortic Valves

Presenter: Raj R. Makkar

October 06, 2015

News Industry News

HeartMate 3™ CE Mark Trial Meets Primary Endpoint

September 28, 2015

News Daily News

Registry Data Show Low Complication Rates With Open Surgical Access for Transfemoral TAVR

Todd Neale

September 14, 2015

News Daily News

Small Series Positive for Novel Transcatheter Mitral Valve in Functional MR

August 25, 2015

News Daily News

CHOICE at 1 Year: Sapien, CoreValve Yield Similar Clinical Outcomes

August 11, 2015

News Daily News

COMPARE: EES Maintains Advantage Over PES at 5 Years

Salynn Boyles

July 30, 2015

News Daily News

BASKET-PROVE Substudy: DES Better Than BMS in Elderly Patients With Large Arteries

Yael L. Maxwell

July 29, 2015

News Industry News

NICE recommends once-daily LIXIANA® (edoxaban) for the treatment and prevention of recurrent Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE) in adults

July 13, 2015

News Daily News

After Pulmonary Embolism, Benefit of Secondary Anticoagulation Does Not Persist

L.A. McKeown

July 13, 2015

News Daily News

Bridging Therapy for A-fib Patients Fails to Prevent Thromboembolism, Increases Bleeding

Yael L. Maxwell

July 10, 2015

News Industry News

Daiichi Sankyo gets EU OK for Lixiana anticoagulant

June 26, 2015

News Industry News

Idarucizumab Reverses the Anticoagulant Effect of Dabigatran Within Minutes in Patient Study

June 22, 2015

Advertisement

Valve Thrombosis/Leaflet Thickening: To Treat or Not to Treat

Companies With Innovative Technologies Compete in TCT Shark Tank

St. Jude Medical Announces CE Mark Approval for the HeartMate 3 Left Ventricular Assist System

Global TAVR Market Poised to Exceed DES Market by 2025

Cath Lab Economics: Pursuit of a Light at the End of the Tunnel

在人工动脉瓣中二尖瓣运动降低并不少见，但可通过抗凝予以治疗

Reduced Leaflet Motion in Bioprosthetic Aortic Valves Not Uncommon But Remedied by Anticoagulation

El Menor Movimiento de las Valvas en las Válvulas Aórticas Bioprotésicas es Habitual Pero puede Remediarse con el Uso de Anticoagulación

Possible Subclinical Leaflet Thrombosis in Bioprosthetic Aortic Valves

HeartMate 3™ CE Mark Trial Meets Primary Endpoint

Registry Data Show Low Complication Rates With Open Surgical Access for Transfemoral TAVR

Small Series Positive for Novel Transcatheter Mitral Valve in Functional MR

CHOICE at 1 Year: Sapien, CoreValve Yield Similar Clinical Outcomes

COMPARE: EES Maintains Advantage Over PES at 5 Years

BASKET-PROVE Substudy: DES Better Than BMS in Elderly Patients With Large Arteries

NICE recommends once-daily LIXIANA® (edoxaban) for the treatment and prevention of recurrent Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE) in adults

After Pulmonary Embolism, Benefit of Secondary Anticoagulation Does Not Persist

Bridging Therapy for A-fib Patients Fails to Prevent Thromboembolism, Increases Bleeding

Daiichi Sankyo gets EU OK for Lixiana anticoagulant

Idarucizumab Reverses the Anticoagulant Effect of Dabigatran Within Minutes in Patient Study

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content